 | Up a level |
Journal Article
Barbui, T., Vannucchi, A. M., Buxhofer-Ausch, V., De Stefano, V., Betti, S., Rambaldi, A., Rumi, E., Ruggeri, M., Rodeghiero, F., Randi, M. L., Bertozzi, I., Gisslinger, H., Finazzi, G., Carobbio, A., Thiele, J., Passamonti, F., Falcone, C. and Tefferi, A. (2015). Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia. Blood Cancer J., 5. LONDON: NATURE PUBLISHING GROUP. ISSN 2044-5385
Gisslinger, H., Jeryczynski, G., Gisslinger, B., Wolfler, A., Burgstaller, S., Buxhofer-Ausch, V., Schalling, M., Krauth, M-T, Schiefer, A-I, Kornauth, C., Simonitsch-Klupp, I., Beham-Schmid, C., Mullauer, L. and Thiele, J. (2016). Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria. Leukemia, 30 (5). S. 1126 - 1133. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551
Jeryczynski, G., Albert, W., Gisslinger, B., Schalling, M., Burgstaller, S., Buxhofer-Ausch, V., Krauth, M. T., Geissler, K., Schloegl, E., Sliwa, T., Schiefer, A. I., Muellauer, L., Simonitsch-Klupp, I., Beham-Schmid, C., Thiele, J. and Gisslinger, H. (2016). A MULTICENTER EVALUATION OF THE REVISED 2015 WHO MINOR CRITERIA FOR PREFIBROTIC PRIMARY MYELOFIBROSIS. Haematologica, 101. S. 556 - 557. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078
Knoebl, P., Voelker, L., Brinkkoetter, P., Kaufeld, J., Menne, J., Buxhofer-Ausch, V. and Miesbach, W. (2020). Treatment of acquired thrombotic thrombocytopenic purpura without plasma exchange in selected patients under caplacizumab. Oncol. Res. Treat., 43 (SUPPL 4). S. 84 - 85. BASEL: KARGER. ISSN 2296-5262
Schalling, M., Gisslinger, B., Jeryczynski, G., Berg, T., Harutyunyan, A., Milosevic, J., Bagienski, K., Them, N., Schischlik, F., Buxhofer-Ausch, V., Nirnberger, G., Schiefer, A. -I., Muellauer, L., Kralovics, R., Thiele, J. and Gisslinger, H. (2015). IMPACT OF CALR AND ASXL1 MUTATIONS ON SURVIVAL AND DISEASE COMPLICATIONS IN ESSENTIAL THROMBOCYTHEMIA AND PREFIBROTIC PRIMARY MYELOFIBROSIS STRICTLY DIAGNOSED ACCORDING TO THE WHO-CLASSIFICATION. Haematologica, 100. S. 262 - 263. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078